Sun Pharma to acquire nearly 38% stake in Ezerx Health Tech for Rs 28.69 cr

Source: Money Control

The acquisition of shares is to be completed by October 2023 for Ezerx and December 2023 for Agatsa, subject to the satisfactory completion of certain conditions, Sun Pharma added.

Pharmaceutical giant Sun Pharma on October 5 said that it will acquire approximately 37.76 percent stake in Ezerx Health Tech for Rs 28.69 crore. EzeRx is a non-invasive diagnostic and ancillary medical device company.

Additionally, the firm will also acquire an additional 4 percent stake in Agatsa Software Private Limited for Rs 4.5 crore, taking up its stake in the company to 30.13 percent post-closing of all the tranche, Sun Pharma said in a regulatory filing.

Agatsa is engaged in research, development and commercialisation of non-invasive medical devices in the diagnostic health segment by leveraging technology and R&D capabilities.

The acquisition of shares is to be completed by October 2023 for Ezerx and December 2023 for Agatsa, subject to the satisfactory completion of certain conditions, it added.